Diverse etiologies, diagnostic approach, and management of primary adrenal insufficiency in pediatric age
暂无分享,去创建一个
[1] F. Barzaghi,et al. IPEX Syndrome: Improved Knowledge of Immune Pathogenesis Empowers Diagnosis , 2021, Frontiers in Pediatrics.
[2] I. del Valle,et al. Current Insights Into Adrenal Insufficiency in the Newborn and Young Infant , 2020, Frontiers in Pediatrics.
[3] M. Maghnie,et al. Primary Adrenal Insufficiency in childhood: data from a large nationwide cohort. , 2020, The Journal of clinical endocrinology and metabolism.
[4] C. Cheon,et al. Clinical, endocrinological, and molecular features of four Korean cases of cytochrome P450 oxidoreductase deficiency , 2020, Annals of pediatric endocrinology & metabolism.
[5] J. Achermann,et al. Primary adrenal insufficiency: New genetic causes and their long‐term consequences , 2019, Clinical endocrinology.
[6] K. Watterberg,et al. Effect of Prophylaxis for Early Adrenal Insufficiency Using Low-Dose Hydrocortisone in Very Preterm Infants: An Individual Patient Data Meta-Analysis. , 2019, The Journal of pediatrics.
[7] A. Oprea,et al. Novel insights into glucocorticoid replacement therapy for pediatric and adult adrenal insufficiency , 2019, Therapeutic advances in endocrinology and metabolism.
[8] Youn-Jeong Choi,et al. Sphingosine phosphate lyase insufficiency syndrome (SPLIS): A novel inborn error of sphingolipid metabolism. , 2019, Advances in biological regulation.
[9] R. Dineen,et al. Factors impacting on the action of glucocorticoids in patients receiving glucocorticoid therapy , 2018, Clinical endocrinology.
[10] Lara Frommer,et al. Autoimmune Polyendocrinopathy. , 2019, The Journal of clinical endocrinology and metabolism.
[11] Martin A. M. Reijns,et al. DNA Polymerase Epsilon Deficiency Causes IMAGe Syndrome with Variable Immunodeficiency , 2018, American journal of human genetics.
[12] C. Stratakis,et al. An overview of inborn errors of metabolism manifesting with primary adrenal insufficiency , 2018, Reviews in Endocrine and Metabolic Disorders.
[13] J. Ko,et al. A case of an infant suspected as IMAGE syndrome who were finally diagnosed with MIRAGE syndrome by targeted Mendelian exome sequencing , 2018, BMC Medical Genetics.
[14] N. Zelinska. Вроджена гіперплазія надниркових залоз внаслідок дефіциту 21-гідроксилази. Клінічні практичні настанови Ендокринологічного Товариства. Частина 1 , 2018 .
[15] L. Metherell,et al. Sphingosine-1-phosphate lyase mutations cause primary adrenal insufficiency and steroid-resistant nephrotic syndrome , 2017, The Journal of clinical investigation.
[16] M. Dattani,et al. Mitochondrial disease and endocrine dysfunction , 2017, Nature Reviews Endocrinology.
[17] H. Yoo,et al. Mutation Spectrum of STAR and the Founder Effect of p.Q258* in Korean Patients with Congenital Lipoid Adrenal Hyperplasia , 2017, Molecular Medicine.
[18] H. Okano,et al. SAMD9 mutations cause a novel multisystem disorder, MIRAGE syndrome, and are associated with loss of chromosome 7 , 2016, Nature Genetics.
[19] M. Didi,et al. The diagnosis and treatment of adrenal insufficiency during childhood and adolescence , 2016, Archives of Disease in Childhood.
[20] Stefan R Bornstein,et al. Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline. , 2016, The Journal of clinical endocrinology and metabolism.
[21] H. Yoo,et al. Novel Heterozygous Mutations of NR5A1 and Their Functional Characteristics in Patients with 46,XY Disorders of Sex Development without Adrenal Insufficiency , 2015, Hormone Research in Paediatrics.
[22] B. Poll-The,et al. High prevalence of primary adrenal insufficiency in Zellweger spectrum disorders , 2014, Orphanet Journal of Rare Diseases.
[23] C. Flück,et al. Novel Insight into Etiology, Diagnosis and Management of Primary Adrenal Insufficiency , 2014, Hormone Research in Paediatrics.
[24] L. Metherell,et al. Thioredoxin Reductase 2 (TXNRD2) Mutation Associated With Familial Glucocorticoid Deficiency (FGD) , 2014, The Journal of clinical endocrinology and metabolism.
[25] H. Yoo,et al. A review of the literature on common CYP17A1 mutations in adults with 17-hydroxylase/17,20-lyase deficiency, a case series of such mutations among Koreans and functional characteristics of a novel mutation. , 2014, Metabolism: clinical and experimental.
[26] P. Grenier,et al. Primary adrenal insufficiency due to bilateral adrenal hemorrhage-adrenal infarction in the antiphospholipid syndrome: long-term outcome of 16 patients. , 2013, The Journal of clinical endocrinology and metabolism.
[27] Claire Hughes,et al. Familial glucocorticoid deficiency: New genes and mechanisms , 2013, Molecular and Cellular Endocrinology.
[28] B. Poll-The,et al. X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management , 2012, Orphanet Journal of Rare Diseases.
[29] F. Wagner,et al. Mutations in Nicotinamide Nucleotide Transhydrogenase (NNT) cause familial glucocorticoid deficiency , 2012, Nature Genetics.
[30] J. Abdenur,et al. Pearson syndrome: unique endocrine manifestations including neonatal diabetes and adrenal insufficiency. , 2012, Molecular genetics and metabolism.
[31] S. Nelson,et al. Mutations in the PCNA-binding domain of CDKN1C cause IMAGE Syndrome , 2012, Nature Genetics.
[32] L. Metherell,et al. MCM4 mutation causes adrenal failure, short stature, and natural killer cell deficiency in humans. , 2012, The Journal of clinical investigation.
[33] J. Ko,et al. Clinical phenotype and mutation spectrum of the CYP21A2 gene in patients with steroid 21-hydroxylase deficiency. , 2012, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
[34] Ji Eun Lee,et al. High allele frequency of the p.Q258X mutation and identification of a novel mis-splicing mutation in the STAR gene in Korean patients with congenital lipoid adrenal hyperplasia. , 2011, European journal of endocrinology.
[35] D. Berney,et al. Nonclassic lipoid congenital adrenal hyperplasia masquerading as familial glucocorticoid deficiency. , 2009, The Journal of clinical endocrinology and metabolism.
[36] T. Webb,et al. The majority of adrenocorticotropin receptor (melanocortin 2 receptor) mutations found in familial glucocorticoid deficiency type 1 lead to defective trafficking of the receptor to the cell surface. , 2008, The Journal of clinical endocrinology and metabolism.
[37] H. Yoo,et al. Identification of Novel Mutations of the DAX-1 Gene in Patients with X-Linked Adrenal Hypoplasia Congenita , 2005, Hormone Research in Paediatrics.
[38] F. Rüschendorf,et al. Mutations in MRAP, encoding a new interacting partner of the ACTH receptor, cause familial glucocorticoid deficiency type 2 , 2005, Nature Genetics.
[39] M. Nowaczyk,et al. Adrenal insufficiency and hypertension in a newborn infant with Smith-Lemli-Opitz syndrome. , 2001, American journal of medical genetics.
[40] G. Bryson,et al. Lysosomal acid lipase mutations that determine phenotype in Wolman and cholesterol ester storage disease. , 1999, Molecular genetics and metabolism.
[41] G. Clayden,et al. FAMILIAL GLUCOCORTICOID DEFICIENCY WITH ACHALASIA OF THE CARDIA AND DEFICIENT TEAR PRODUCTION , 1978, The Lancet.